Patents/Assignees

Agomab Therapeutics

2 patents in portfolio

US12084504utility2024
Anti-met Antibodies and Uses Thereof
0 cites
US11834507utility2023
Anti-met Agonist Antibody for Use in the Treatment of Colorectal Cancer
0 cites